国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2011年
18期
2214-2217
,共4页
梁伦昌%陈文智%陈伟泉%谭其平
樑倫昌%陳文智%陳偉泉%譚其平
량륜창%진문지%진위천%담기평
赖诺普利%曲美他嗪%血管内皮功能%糖化血红蛋白%心脏事件
賴諾普利%麯美他嗪%血管內皮功能%糖化血紅蛋白%心髒事件
뢰낙보리%곡미타진%혈관내피공능%당화혈홍단백%심장사건
Lisinopril%Trimetazidine%Blood vessel endothelium function%Glycosylated hemoglobin%Heart event
目的 探讨赖诺普利、曲美他嗪对急性冠脉综合征合并2型糖尿病患者血管内皮功能及糖化血红蛋白的影响,及心脏事件发生情况。方法 治疗组采用赖诺普利、曲美他嗪治疗,对照组采用传统方法治疗;在改善血管内皮功能、降低糖化血红蛋白、防治心血管事件等方面比较疗效。结果 治疗组在改善血管内皮功能、降低糖化血红蛋白(7.0%vs.8.0%)、防治心血管事件(13例vs.23例)等方面优于对照组。结论 赖诺普利、曲美他嗪对急性冠脉综合征合并2型糖尿病患者,可显著改善血管内皮功能、降低糖化血红蛋白、防治心血管事件,患者多方面受益。
目的 探討賴諾普利、麯美他嗪對急性冠脈綜閤徵閤併2型糖尿病患者血管內皮功能及糖化血紅蛋白的影響,及心髒事件髮生情況。方法 治療組採用賴諾普利、麯美他嗪治療,對照組採用傳統方法治療;在改善血管內皮功能、降低糖化血紅蛋白、防治心血管事件等方麵比較療效。結果 治療組在改善血管內皮功能、降低糖化血紅蛋白(7.0%vs.8.0%)、防治心血管事件(13例vs.23例)等方麵優于對照組。結論 賴諾普利、麯美他嗪對急性冠脈綜閤徵閤併2型糖尿病患者,可顯著改善血管內皮功能、降低糖化血紅蛋白、防治心血管事件,患者多方麵受益。
목적 탐토뢰낙보리、곡미타진대급성관맥종합정합병2형당뇨병환자혈관내피공능급당화혈홍단백적영향,급심장사건발생정황。방법 치료조채용뢰낙보리、곡미타진치료,대조조채용전통방법치료;재개선혈관내피공능、강저당화혈홍단백、방치심혈관사건등방면비교료효。결과 치료조재개선혈관내피공능、강저당화혈홍단백(7.0%vs.8.0%)、방치심혈관사건(13례vs.23례)등방면우우대조조。결론 뢰낙보리、곡미타진대급성관맥종합정합병2형당뇨병환자,가현저개선혈관내피공능、강저당화혈홍단백、방치심혈관사건,환자다방면수익。
Objective To explore effects of lisinopril and trimetazidine treating acute coronary artery syndrome combined with 2-type diabetes mellitus, such as blood vessel endothelium function and glycosylated hemoglobin effect and heart blood vessel event of acute coronary artery syndrome combined with 2-type diabetes mellitus. Methods Therapy group offered lisinopril and trimetazidine, control group received traditional method, compared with curative effect of improving blood vessel endothelium function, depressing glycosylated hemoglobin, preventing and curing heart blood vessel event. Results Therapy group is better than control group in improving blood vessel endothelium function, depressing glycosylated hemoglobin, preventing and curing heart blood vessel event. Conclusion Lisinopril and trimetazidine can improve blood vessel endothelium function, depress glycosylated hemoglobin, prevent and cure heart blood vessel event of acute coronary artery syndrome combined wih 2-type diabetes mellitus.Patients can benefit from it in many ways.